Clinical Trials Sponsored by IDEA AG

Total 2421 results

IDEA AG

Completed

Safety and Efficacy of Two Dosages of Diractin® in Osteoarthritis (OA)

Osteoarthritis of the Knee

Poland, United Kingdom, Czech Republic, Germany
IDEA AG

Completed

Multi-Centre, Open-Label, Two Segment, Study Comparing Plasma Pharmacokinetics of Ketoprofen in Diractin® Alone to Diractin® Applied Concomitant With Heat or Moderate Exercise

Pharmacokinetic

Germany
IDEA AG

Completed

IDEA-033 Open Label Study

Joint Pain | Musculoskeletal Pain | Stiffness | Soft Tissue Inflammation in Designated Target Area(s)

Germany
IDEA AG

Completed

Study of Safety and Efficacy of Diractin® for the Treatment of Osteoarthritis (OA) of the Knee

Osteoarthritis of the Knee

United States
IDEA AG

Completed

Effect of IDEA-070 on Pain and Inflammation Induced by PDT

Actinic Keratosis

Germany
IDEA AG

Completed

IDEA-033 Three Months Dose Finding in OA Followed by IDEA-033 Three Months Extension in OA

Osteoarthritis; Knee
IDEA AG

Completed

Ketoprofen in Transfersome Compared to Oral Celecoxib and Placebo for Pain Associated With Osteoarthritis of the Knee

Osteoarthritis, Knee
IDEA AG

Completed

Multiple Dose, Double-Blind, Placebo and Active Controlled Study of Pharmacokinetics of Diractin® as Well as Safety and Efficacy for the Treatment of Muscle Soreness

Muscle Soreness

Germany
IDEA AG

Completed

An Effectiveness and Safety Study of IDEA-033 in Comparison to Oral Naproxen and Placebo for the Treatment of Osteoarthritis of the Knee

Osteoarthritis, Knee

United States
IDEA AG

Completed

A Long-Term Safety Study of IDEA-033 in Comparison to Oral Naproxen for the Treatment of Osteoarthritis of the Knee

Osteoarthritis, Knee

United States
IGEA

Terminated

Safety and Feasibility of Electrochemotherapy in Unresectable Colorectal Adenocarninoma Liver Metastases

Colorectal Adenocarcinoma
IMDEA Food

Completed

Human Study of Functional Meat Products

Healthy Volunteers

Spain
IMDEA Food

Active, not recruiting

Platform for Clinical Trials in Nutrition and Health (GENYALPlatform)

Healthy Volunteers

Spain
IMDEA Food

Completed

Description of Immunosenescence Biomarkers and Nutritional Intervention to Evaluate the Implementation of Digital Tools

Chronic Disease

Spain
IMDEA Food

Completed

Targeting DNA-methylation Fingerprints Linked to Ultra-Processed Foods Consumption to Prevent Non-communicable Diseases: the METHYL-UP Study (METHYL-UP)

Obesity | Overweight

Spain
IMDEA Food

Completed

Study of the Consumption of a Food Supplement in a Group of Healthy People (FORCANCER)

Immune System and Related Disorders

Spain
IMDEA Food

Completed

Human Study of Hydroxytyrosol on Phase II Enzymes in Healthy Subjects

Healthy

Spain
IMDEA Food

Completed

GENYAL Study to Childhood Obesity Prevention

Childhood Onset Obesity

Spain
Idera Pharmaceuticals, Inc.

Completed

A Study of Intratumoral IMO-2125 in Patients With Refractory Solid Tumors (ILLUMINATE-101)

Melanoma | Refractory Solid Tumors

United States, Israel
Idera Pharmaceuticals, Inc.

Terminated

Phase 1/2 Dose Escalation Study in Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia (8400-401)

Waldenstrom's Macroglobulinemia

United States
Idera Pharmaceuticals, Inc.

Completed

Study of IMO-2055 in Metastatic or Locally Recurrent Clear Cell Renal Carcinoma

Renal Cell Carcinoma

United States
Idera Pharmaceuticals, Inc.

Completed

Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis

Moderate to Severe Plaque Psoriasis | Actively Extending Plaque Psoriasis

United States
University of Nebraska
Great Plains IDeA-CTR

Suspended

Assessing Continuous Glucose Monitor Use in Underserved Primary Care Patients

Type 2 Diabetes

United States
Ideal Implant Incorporated

Completed

Core Study of the Safety and Effectiveness of IDEAL IMPLANT(R) Saline-filled Breast Implants

Breast Implants

United States
Ideal Implant Incorporated

Completed

Upright Magnetic Resonance Imaging (MRI) Study - Breast Implant Shell Geometry and Edge Scalloping

Breast Augmentation
University of Nebraska
Great Plains IDeA-CTR

Completed

Evaluation of Changes in Brain Connectivity After Tumor Resection

Brain Tumor

United States
Universita di Verona
IGEA

Terminated

Electrochemoterapy With Bleomycin for the Treatment of Unresectable Pancreatic Cancer

Pancreatic Cancer

Italy
Idera Pharmaceuticals, Inc.

Completed

A Phase 2 Study to Assess the Safety and Efficacy of IMO-2125 With 8 mg Ipilimumab in Patients With Metastatic Melanoma

Metastatic Melanoma

United States
Idera Pharmaceuticals, Inc.

Completed

A 12-week Dose-Ranging Trial in Patients With Moderate to Severe Plaque Psoriasis (8400-201)

Plaque Psoriasis

Netherlands
Idera Pharmaceuticals, Inc.

Completed

Trial of IMO-8400 in Adult Patients With Dermatomyositis (8400-211)

Dermatomyositis

United States, Hungary, United Kingdom
Idera Pharmaceuticals, Inc.

Completed

Placebo-controlled, Dose-escalation Study of the Safety of IMO-2125 (Immunomodulatory Oligonucleotide) in Hepatitis C-infected Patients

Hepatitis C

United States, Puerto Rico
Idera Pharmaceuticals, Inc.

Completed

Study of Combination Treatment With IMO-2125 and Ribavirin in Naïve Hepatitis C-infected, Genotype 1 Patients

Hepatitis C, Treatment Naïve, Genotype 1 Patients

France
Idera Pharmaceuticals, Inc.

Completed

Extension Study of IMO-8400 in Patients With Waldenström's Macroglobulinemia Who Completed Study 8400-401

Waldenstrom's Macroglobulinemia
Idera Pharmaceuticals, Inc.

Completed

Dose Escalation Study in Patients With Relapsed or Refractory DLBCL and MyD88 L265P Mutation

Diffuse Large B Cell Lymphoma

United States
Fundacion IDEAA
ViiV Healthcare

Completed

Efficacy of Dolutegravir Plus Lamivudine in HIV-1-infected Treatment-naïve Adults Without a Baseline Genotyping Test (D2ARLING)

Hiv | HIV-1-infection

Argentina
AbbVie
Idera Pharmaceuticals, Inc.

Completed

A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-368 Plus Tilsotolimod and Other Therapy Combinations in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Advanced Solid Tumors Cancer

United States, France, Germany, Israel, Netherlands, Spain
Tulane University
Ideal Protein

Completed

A Trial of the Ideal Protein System Versus Low Fat Diet for Weight Loss (RENEWAL)

Weight Loss

United States
Biogen
Biogen Idec A/S

Completed

A Single-blinded, Controlled, Multi-centre Study of Effects of Exercise in Participants With Multiple Sclerosis (ACTIMS)

Exercise

Sweden, Finland, New Zealand, Denmark, Norway, Australia
Bottneuro AG
Hemex AG

Active, not recruiting

Evaluate the Safety and Feasibility of tACS With the Miamind Neurostimulator in Healthy Participants (MindStim)

Healthy Participants | Healthy Population

Switzerland
Santersus AG
ISS AG

Not yet recruiting

Safety, Tolerability and Performance of the NucleoCapture Device in the Reduction of Circulating cfDNA/NETs in Subjects With Sepsis (NUC-CAP)

Sepsis | Respiratory Failure

United Kingdom, Germany, Switzerland
SynDermix AG
ISS AG

Withdrawn

Safety and Efficacy of SDX-3101 for the Treatment of Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP) (SDX-3101)

Chronic Rhinosinusitis Without Nasal Polyps

Germany, Austria, Switzerland
Tetec AG
Aesculap AG

Completed

Observational Study With NOVOCART® Inject in the Reconstruction of the Hip Joint With Full Thickness Cartilage Defects (HIP-ACTION)

Cartilage Disease

Germany
Jiangsu Aidea Pharmaceutical Co., Ltd
Chengdu Aidea Pharmaceutical Technology Co., Ltd

Recruiting

Single Ascending Dose, Food Effects and Drug-Drug Interactions of ACC017 Tablets in Healthy Adult Participants

Healthy Adult Participants

China
Tetec AG
Aesculap AG

Completed

Non-Interventional Study to Evaluate Safety and Efficacy of NOVOCART 3D in Patients With Cartilage Defects (NISANIK)

Cartilage Diseases

Germany
Ideal Medical Technologies
Emory University

Completed

Closed Loop Glucose Control in Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

United States
Mayo Clinic
Gamma Medica-Ideas

Completed

Use of Molecular Breast Imaging (MBI) to Detect Additional Disease in Women With Breast Cancer Who Are About to go to Surgery (MBI)

Breast Cancer

United States
Idera Pharmaceuticals, Inc.
Bristol-Myers Squibb

Terminated

A Study of Tilsotolimod in Combo With Ipilimumab vs Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma

Metastatic Melanoma

United States, Canada, Spain, United Kingdom, France, Australia, Germany, Italy, Netherlands, Sweden, Czechia
Ideal Medical Technologies
Emory University

Recruiting

Closed Loop Glucose Control in Patients With Type 1 and Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

United States
Mayo Clinic
Gamma Medica-Ideas

Completed

Screening in Myocardial Perfusion Patients

Breast Cancer

United States
Mayo Clinic
Gamma Medica-Ideas

Completed

Hormonal Effects on Tc-99m Sestamibi Uptake in the Breast

Breast Cancer

United States

3

Subscribe